ATOS
Atossa Genetics Inc
NASDAQ: ATOS · HEALTHCARE · BIOTECHNOLOGY
$5.37
+1.70% today
Updated 2026-04-30
Market cap
$49.09M
P/E ratio
—
P/S ratio
1,872.06x
EPS (TTM)
$-4.04
Dividend yield
—
52W range
$4 – $19
Volume
0.1M
Atossa Genetics Inc (ATOS) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |